Literature DB >> 3925934

Intraneuronal accumulation of myeloma proteins.

L F Borges, N A Busis.   

Abstract

We studied a patient with multiple myeloma who had immunologically identified myeloma light chain proteins within neurons projecting beyond the blood-brain barrier, but not within intrinsic neurons of the spinal cord, brain stem, and cerebral cortex. There was a possibility that these myeloma light chain proteins or their immunologically recognizable fragments were transported intra-axonally by human peripheral nerves. Myeloma light chain proteins were also identified within cerebellar Purkinje's neurons. This labeling may have been secondary to transport from cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925934     DOI: 10.1001/archneur.1985.04060070084021

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  14 in total

1.  Reactivity of circulating antineuronal antibodies (CANA) on peripheral nervous system structures.

Authors:  W Grisold; M Drlicek; U Liszka; K Jellinger; W Popp
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

2.  Paraneoplastic cerebellar degeneration associated with multiple myeloma--3.4 years follow up.

Authors:  S Akpinar; O Berk; L Karaca
Journal:  J Neurooncol       Date:  1990-08       Impact factor: 4.130

3.  Purkinje cell death after uptake of anti-Yo antibodies in cerebellar slice cultures.

Authors:  John E Greenlee; Susan A Clawson; Kenneth E Hill; Blair L Wood; Ikuo Tsunoda; Noel G Carlson
Journal:  J Neuropathol Exp Neurol       Date:  2010-10       Impact factor: 3.685

4.  Human serum Cohn fraction IV (alpha-globulin [correction of globin] enriched) inhibits ligand binding at neurotransmitter receptors in human brain.

Authors:  A C Andorn; M A Pappolla; H Fox; F K Klemens; P A Martello
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Autoantibodies directed against glutamate decarboxylase interfere with glucose-stimulated insulin secretion in dispersed rat islets.

Authors:  Varun Kamat; Jared R Radtke; Qingxun Hu; Wang Wang; Ian R Sweet; Christiane S Hampe
Journal:  Int J Exp Pathol       Date:  2022-03-04       Impact factor: 2.793

6.  Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics.

Authors:  Kenneth E Hill; Susan A Clawson; John W Rose; Noel G Carlson; John E Greenlee
Journal:  J Neuroinflammation       Date:  2009-10-29       Impact factor: 8.322

7.  Diphtheria toxin mutant selectively kills cerebellar Purkinje neurons.

Authors:  C J Riedel; K M Muraszko; R J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

8.  Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption.

Authors:  J E Greenlee; J B Burns; J W Rose; K A Jaeckle; S Clawson
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 9.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 10.  Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.

Authors:  Hiroshi Mitoma; Keya Adhikari; Daniel Aeschlimann; Partha Chattopadhyay; Marios Hadjivassiliou; Christiane S Hampe; Jérôme Honnorat; Bastien Joubert; Shinji Kakei; Jongho Lee; Mario Manto; Akiko Matsunaga; Hidehiro Mizusawa; Kazunori Nanri; Priya Shanmugarajah; Makoto Yoneda; Nobuhiro Yuki
Journal:  Cerebellum       Date:  2016-04       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.